Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 30,766 shares at $1.65 ($51K) on 2023-08-16, disclosed to the SEC on 2023-08-18.
Seasonal sale ($51k) by President and CEO — this insider has traded ATRA in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 9,334 | $15K | 30.3% |
| 2 | $1.65 | 21,432 | $35K | 69.7% |
| Total | $1.65 avg | 30,766 | $51K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-06-29 | $24K | — | Filing → |